Northern Trust’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,323
| Closed | -$218K | – | 4778 |
|
|
2022
Q1 | $218K | Sell |
6,323
-767
| -11% | -$26.4K | ﹤0.01% | 4103 |
|
|
2021
Q4 | $311K | Buy |
7,090
+90
| +1% | +$3.95K | ﹤0.01% | 4007 |
|
|
2021
Q3 | $355K | Sell |
7,000
-500
| -7% | -$25.4K | ﹤0.01% | 3904 |
|
|
2021
Q2 | $390K | Hold |
7,500
| – | – | ﹤0.01% | 3823 |
|
|
2021
Q1 | $343K | Sell |
7,500
-500
| -6% | -$22.9K | ﹤0.01% | 3932 |
|
|
2020
Q4 | $368K | Hold |
8,000
| – | – | ﹤0.01% | 3804 |
|
|
2020
Q3 | $312K | Hold |
8,000
| – | – | ﹤0.01% | 3708 |
|
|
2020
Q2 | $304K | Buy |
+8,000
| New | +$304K | ﹤0.01% | 3657 |
|